Effect of renal impairment on the pharmacokinetics of levomilnacipran following a single oral dose of levomilnacipran extended-release capsule in humans

• Main Authors: Chen L (Author), Greenberg WM (Author), Brand-Schieber E (Author), Wangsa J (Author), Periclou A (Author), Ghahramani P (Author)
• Format: Book
• Published: Dove Medical Press, 2015-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Laishun Chen, William M Greenberg, Elimor Brand-Schieber, Julie Wangsa, Antonia Periclou, Parviz Ghahramani Forest Research Institute, a subsidiary of Actavis Inc., Jersey City, NJ, USA Purpose: Levomilnacipran extended-release (ER) is indicated for treatment of major depressive disorder in adults....